| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.3M | +0.0% |
| R&D Expense | $11.9M | +83.2% |
| SG&A Expense | $12.7M | +18.6% |
| Operating Income | -$24.6M | -54.3% |
| Income Tax | $0 | — |
| Net Income | -$26.2M | -70.7% |
| EPS (Basic) | -$1.66 | -53.7% |
| EPS (Diluted) | -$1.66 | -53.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.3M | -81.7% |
| Current Assets | $3.5M | -87.5% |
| Total Assets | $11.6M | -67.9% |
| Current Liabilities | $19.0M | -34.9% |
| Total Liabilities | $28.4M | -25.3% |
| Stockholders' Equity | -$16.8M | -872.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$30.3M | — |
| Capital Expenditures | $171K | +211.5% |
| Investing Cash Flow | -$171K | -211.5% |
| Financing Cash Flow | $20.0M | +180.7% |
| Free Cash Flow | -$30.4M | — |